Director, Medical Affairs
Illumina180,000 - 220,000 USD/year
- Full Time
- Mid-level (3 to 4 years), Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Genomics, DiagnosticsIndustries
Requirements
The Senior Director of Product Management should possess a Bachelor’s degree and have at least 8 years of product management experience, with a preference for experience in the diagnostic or genomics industry, and a strong understanding of oncology, molecular biology, and data science. They should also have experience in developing and executing product strategies, conducting market research, and building business plans with financial modeling, as well as demonstrated leadership skills and the ability to collaborate effectively with cross-functional teams.
Responsibilities
This role involves gathering and analyzing internal and external data to identify unmet customer needs, crafting product concepts, and proposing target product profiles, coordinating with R&D, Data Science, Medical, Business Development, and Marketing teams to evaluate new product concepts, conducting VOC interviews and market research, leading the development of long-term business plans with financial analysis, evaluating model sensitivities, and making investment recommendations based on rigorous business analysis and market research. The individual will also mature new products through research and proof-of-concept, and collaborate with the broader Product team to transition these products to development and eventual launch.
Skills
Oncology market knowledge
Diagnostic landscape understanding
Product Management
Molecular diagnostics
Genomics
Molecular biology
Data science
AI/ML
Market research
Competitive analysis
VOC interviews
Financial modeling
Business acumen
Leadership
Cross-functional collaboration
Natera
Genetic testing and diagnostics solutions provider
About Natera
Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.
Key Metrics
Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees